BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 35563037)

  • 1. Extracellular Matrix Biomimetic Hydrogels, Encapsulated with Stromal Cell-Derived Factor 1, Improve the Composition of Foetal Tissue Grafts in a Rodent Model of Parkinson's Disease.
    Penna V; Moriarty N; Wang Y; Law KCL; Gantner CW; Williams RJ; Nisbet DR; Parish CL
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying the optimal developmental age of human pluripotent stem cell-derived midbrain dopaminergic progenitors for transplantation in a rodent model of Parkinson's disease.
    de Luzy IR; Pavan C; Moriarty N; Hunt CPJ; Vandenhoven Z; Khanna A; Niclis JC; Gantner CW; Thompson LH; Parish CL
    Exp Neurol; 2022 Dec; 358():114219. PubMed ID: 36055392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding the Influence of Target Acquisition on Survival, Integration, and Phenotypic Maturation of Dopamine Neurons within Stem Cell-Derived Neural Grafts in a Parkinson's Disease Model.
    Moriarty N; Kauhausen JA; Pavan C; Hunt CPJ; de Luzy IR; Penna V; Ermine CM; Thompson LH; Parish CL
    J Neurosci; 2022 Jun; 42(25):4995-5006. PubMed ID: 35610045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meningeal cells influence midbrain development and the engraftment of dopamine progenitors in Parkinsonian mice.
    Somaa FA; Bye CR; Thompson LH; Parish CL
    Exp Neurol; 2015 May; 267():30-41. PubMed ID: 25708989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.
    Kriks S; Shim JW; Piao J; Ganat YM; Wakeman DR; Xie Z; Carrillo-Reid L; Auyeung G; Antonacci C; Buch A; Yang L; Beal MF; Surmeier DJ; Kordower JH; Tabar V; Studer L
    Nature; 2011 Nov; 480(7378):547-51. PubMed ID: 22056989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Birth dating of midbrain dopamine neurons identifies A9 enriched tissue for transplantation into parkinsonian mice.
    Bye CR; Thompson LH; Parish CL
    Exp Neurol; 2012 Jul; 236(1):58-68. PubMed ID: 22524988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease.
    Peng SP; Copray S
    Stem Cell Rev Rep; 2016 Feb; 12(1):105-20. PubMed ID: 26438376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptide-Based Scaffolds for the Culture and Transplantation of Human Dopaminergic Neurons.
    Francis NL; Zhao N; Calvelli HR; Saini A; Gifford JJ; Wagner GC; Cohen RI; Pang ZP; Moghe PV
    Tissue Eng Part A; 2020 Feb; 26(3-4):193-205. PubMed ID: 31537172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Parkinson's disease model composed of 3D bioprinted dopaminergic neurons within a biomimetic peptide scaffold.
    Abdelrahman S; Alsanie WF; Khan ZN; Albalawi HI; Felimban RI; Moretti M; Steiner N; Chaudhary AG; Hauser CAE
    Biofabrication; 2022 Jul; 14(4):. PubMed ID: 35793642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Encapsulation of primary dopaminergic neurons in a GDNF-loaded collagen hydrogel increases their survival, re-innervation and function after intra-striatal transplantation.
    Moriarty N; Pandit A; Dowd E
    Sci Rep; 2017 Nov; 7(1):16033. PubMed ID: 29167483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pretreatment with Perlecan-Conjugated Laminin-E8 Fragment Enhances Maturation of Grafted Dopaminergic Progenitors in Parkinson's Disease Model.
    Adachi H; Morizane A; Torikoshi S; Raudzus F; Taniguchi Y; Miyamoto S; Sekiguchi K; Takahashi J
    Stem Cells Transl Med; 2022 Jul; 11(7):767-777. PubMed ID: 35605097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.
    Kirkeby A; Nolbrant S; Tiklova K; Heuer A; Kee N; Cardoso T; Ottosson DR; Lelos MJ; Rifes P; Dunnett SB; Grealish S; Perlmann T; Parmar M
    Cell Stem Cell; 2017 Jan; 20(1):135-148. PubMed ID: 28094017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurite Outgrowth and Gene Expression Profile Correlate with Efficacy of Human Induced Pluripotent Stem Cell-Derived Dopamine Neuron Grafts.
    Hills R; Mossman JA; Bratt-Leal AM; Tran H; Williams RM; Stouffer DG; Sokolova IV; Sanna PP; Loring JF; Lelos MJ
    Stem Cells Dev; 2023 Jul; 32(13-14):387-397. PubMed ID: 37166357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of young donor age dopaminergic grafts in a GDNF-loaded collagen hydrogel further increases their survival, reinnervation, and functional efficacy after intrastriatal transplantation in hemi-Parkinsonian rats.
    Moriarty N; Cabré S; Alamilla V; Pandit A; Dowd E
    Eur J Neurosci; 2019 Feb; 49(4):487-496. PubMed ID: 30054941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent effect of mesenchymal stromal cells co-grafted with dopaminergic neurons in a Parkinson's disease rat model.
    Rodriguez-Pallares J; Garcia-Garrote M; Parga JA; Labandeira-Garcia JL
    J Cell Mol Med; 2021 Oct; 25(20):9884-9889. PubMed ID: 34535974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation of LMX1a Ventral Midbrain Progenitors Improves the Safety and Predictability of Human Pluripotent Stem Cell-Derived Neural Transplants in Parkinsonian Disease.
    de Luzy IR; Niclis JC; Gantner CW; Kauhausen JA; Hunt CPJ; Ermine C; Pouton CW; Thompson LH; Parish CL
    J Neurosci; 2019 Nov; 39(48):9521-9531. PubMed ID: 31641054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-step grafting significantly enhances the survival of foetal dopaminergic transplants and induces graft-derived vascularisation in a 6-OHDA model of Parkinson's disease.
    Büchele F; Döbrössy M; Hackl C; Jiang W; Papazoglou A; Nikkhah G
    Neurobiol Dis; 2014 Aug; 68():112-25. PubMed ID: 24780496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The controlled conversion of human neural progenitor cells derived from foetal ventral mesencephalon into dopaminergic neurons in vitro.
    Riaz SS; Jauniaux E; Stern GM; Bradford HF
    Brain Res Dev Brain Res; 2002 May; 136(1):27-34. PubMed ID: 12036514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Embryonic ventral mesencephalic grafts to the substantia nigra of MPTP-treated monkeys: feasibility relevant to multiple-target grafting as a therapy for Parkinson's disease.
    Collier TJ; Sortwell CE; Elsworth JD; Taylor JR; Roth RH; Sladek JR; Redmond DE
    J Comp Neurol; 2002 Jan; 442(4):320-30. PubMed ID: 11793337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell intrinsic and extrinsic factors contribute to enhance neural circuit reconstruction following transplantation in Parkinsonian mice.
    Kauhausen J; Thompson LH; Parish CL
    J Physiol; 2013 Jan; 591(1):77-91. PubMed ID: 23045338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.